Authors : D. Umamaheswari; R. Senthil Prabhu; T. Venkata Rathina Kumar; K. Gayathri; M. Rubika; S. Sarathi; S. Selvakumar; R. Sowmiya

Volume/Issue : Volume 11 - 2026, Issue 6 - June

Google Scholar : https://tinyurl.com/35zu7rdb

Scribd : https://tinyurl.com/ya9rc492

DOI : https://doi.org/10.38124/ijisrt/26jun617

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : In the fields of pharmaceutical sciences and biomedical engineering, additive manufacturing—also known as three-dimensional (3D) printing—has emerged as a revolutionary technology [1]. This technology, in contrast to traditional manufacturing methods, makes it possible to produce complicated dosage forms, biomedical implants, tissue scaffolds, and customized drug delivery systems with exact control over drug dose and release characteristics [3]. Its uses in organ restoration, tissue engineering, wound healing, oral dosage forms, and ocular medication administration have increased recently. Additionally, living tissues and organ models for drug screening and regenerative medicine have been made possible by 3D bioprinting. Notwithstanding its encouraging promise, issues with pricing, scalability, and regulatory approval still exist. This article examines the leading pharmaceutical company and emphasizes its contribution to the advancement of regenerative medicine and sophisticated drug delivery technologies.

Keywords : 3D Printing, Additive Manufacturing, Tissue Engineering, Personalized Medicine, Bioprinting.

References :

1. Ventola CL. Medical applications for 3D printing: current and projected uses. P T. 2014;39(10):704–711.
2. Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D printed drug products. Adv Drug Deliv Rev. 2017;108:39–50.
3. Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 2016;499(1-2):376–394.
4. Gross BC, Erkal JL, Lockwood SY, Chen C, Spence DM. Evaluation of 3D printing and its potential impact on biotechnology and pharmaceutical industries. Anal Chem. 2014;86(7):3240–3253.
5. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printing in pharmaceutical manufacturing. Pharm Res. 2016;33(8):1817–1832.
6. Jamróz W, Szafraniec J, Kurek M, Jachowicz R. 3D printing in pharmaceutical and medical applications. Pharm Res. 2018;35(9):176.
7. Awad A, Fina F, Trenfield SJ, Patel P, Goyanes A, Gaisford S, et al. 3D printed medicines: a new branch of digital healthcare. Int J Pharm. 2018;548(1):586–596.
8. Gioumouxouzis CI, Katsamenis OL, Bouropoulos N, Fatouros DG. 3D printed ocular drug delivery systems. Pharmaceutics. 2020;12(2):1–18.
9. Boateng JS, Okeke O. Chitosan-based ocular drug delivery systems. Drug Dev Ind Pharm. 2016;42(9):1359–1370.
10. Rathbone MJ, Hadgraft J, Roberts MS. Modified-release drug delivery technology for ocular therapy. Adv Drug Deliv Rev. 2015;95:56–71.
11. Alzahrani A, Youssef AAA, Nyavanandi D, Tripathi S, Bandari S, Majumdar S. Design and optimization of ciprofloxacin hydrochloride biodegradable 3D printed ocular inserts. Int J Pharm. 2023;631:122533.
12. Nyavanandi D, et al. Development of 3D printed ocular inserts using fused deposition modeling. AAPS PharmSciTech. 2020;21:1–12.
13. Bandari S, Nyavanandi D, Kallakunta VR, Janga KY, Sarabu S, Butreddy A, et al. 3D printing of pharmaceutical dosage forms. AAPS PharmSciTech. 2020;21(2):1–20.
14. ElShaer A, et al. Ocular drug delivery barriers and strategies. Eur J Pharm Biopharm. 2014;88(1):1–12.
15. Abd-Elsalam WH, et al. Nanovesicles for ocular drug delivery. Drug Deliv. 2021;28(1):1–12.
16. Pereira BC, Isreb A, Forbes RT, Oga EF, Alhnan MA. 3D printing of pharmaceutical dosage forms. Eur J Pharm Sci. 2020;143:105120.
17. Naguib MJ, Hassan YR, Abd-Elsalam WH. 3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis. Int J Pharm. 2021;607:121010.
18. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh F, Javanmard R, Dokhani A, et al. Impact of nanocarriers on drug delivery systems. Pharmaceutics. 2018;10(2):57.
19. Goyanes A, Buanz ABM, Hatton GB, Gaisford S, Basit AW. 3D printing of medicines: engineering novel oral devices. Int J Pharm. 2015;494(2):657–664.
20. Lopez-Vidal L, et al. Nanocrystal loaded 3D printed tablets. Eur J Pharm Sci. 2020;146:105260.
21. Khaled SA, Burley JC, Alexander MR, Roberts CJ. 3D printing of five-in-one dose combination polypill. Nat Commun. 2015;6:5932.
22. Zhang J, et al. Colon targeted drug delivery systems. Adv Drug Deliv Rev. 2017;114:123–135.
23. Okwuosa TC, et al. Fabrication of pH responsive 3D printed tablets. Int J Pharm. 2018;550(1-2):220–231.
24. Chai X, et al. FDM 3D printed colon targeted tablets. Drug Dev Ind Pharm. 2017;43(10):1–8.
25. Li Q, et al. Pill-in-pill 3D printed tablets. Pharmaceutics. 2020;12(2):1–12.
26. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32(8):773–785.
27. Zhao X, et al. 3D printed scaffolds for wound healing. Biomaterials. 2018;181:1–14.
28. Chen Z, et al. Skin tissue engineering using 3D printing. Acta Biomater. 2020;108:1–20.
29. Bose S, Vahabzadeh S, Bandyopadhyay A. Bone tissue engineering using 3D printing. Mater Today. 2013;16(12):496–504.
30. Zhang Y, et al. Drug loaded bone scaffolds. Biomaterials. 2019;200:1–12.
31. Goyanes A, et al. 3D printed intravaginal drug delivery systems. Int J Pharm. 2018;547(1-2):1–9.
32. Tan B, et al. 3D printed ocular prosthesis. Eye. 2018;32(3):1–7.
33. Isaacson A, Swioklo S, Connon CJ. 3D bioprinting of corneal tissue. Exp Eye Res. 2018;173:188–193.
34. Kim H, et al. Bioengineered corneal stromal equivalents. Biomaterials. 2019;203:1–12.
35. Sorkio A, et al. Human stem cell derived corneal constructs. Acta Biomater. 2018;65:1–12.
36. Isaacson A, Swioklo S, Connon CJ. 3D bioprinting of a corneal stroma equivalent. Exp Eye Res. 2018;173:188–193.
37. Khalili M, Asadi M, Kahroba H, Soleyman MR, Andre H, Alizadeh E. Corneal endothelium tissue engineering: an evolution of signaling molecules, cells, and scaffolds toward 3D bioprinting and cell sheets. J Cell Physiol. 2021;236(5):3275–3303.
38. Masaeli E, et al. 3D bioprinting for retinal tissue engineering. Biofabrication. 2020;12(2):1–14.
39. Shi P, Edgar TYS, Yeong WY, Laude A. Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research. Int J Bioprint. 2017.
40. U.S. Food and Drug Administration. FDA approves first 3D printed drug Spritam (levetiracetam) [Internet]. Silver Spring (MD): FDA; 2015.
41. Aprecia Pharmaceuticals. ZipDose technology for rapidly disintegrating tablets [Internet]. Aprecia Pharmaceuticals; 2015.
42. Khaled SA, Alexander MR, Roberts CJ. Personalized polypill using 3D printing technology. Int J Pharm. 2018;542(1-2):1–7.
43. Goyanes A, Madla CM, Umerji A, Duran Piñeiro G, Giraldez Montero JM, Lamas Diaz MJ, et al. 3D printing of medicines for improved patient compliance. Pharmaceutics. 2019;11(9):1–15.
44. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of pharmaceutical polypills. Int J Pharm. 2015;494(2):643–650.
45. Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015;217:308–314.